Patents by Inventor Douglas Hepler

Douglas Hepler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240100014
    Abstract: Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
    Type: Application
    Filed: October 23, 2023
    Publication date: March 28, 2024
    Inventors: Douglas Hepler, Gail L. Dempsey, Roland Johnson, Michael Kelly, Michael Daniel, Neil E. Paulsen, Bert Clayton
  • Patent number: 11375717
    Abstract: A single-dose oral formulation of spinosad and lufenuron and methods for its use in the extended control of a flea infestation on a domestic animal such as a dog without emesis.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: July 5, 2022
    Assignee: Piedmont Animal Health Inc.
    Inventors: Douglas Hepler, Roland Johnson, Gail Dempsey, Michael Kelly
  • Publication number: 20200390688
    Abstract: Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for topical administration.
    Type: Application
    Filed: June 12, 2020
    Publication date: December 17, 2020
    Inventors: Douglas Hepler, Neil E. Paulsen, Michael S. Daniel, Gail L. Dempsey
  • Publication number: 20200359624
    Abstract: A single-dose oral formulation of spinosad and lufenuron and methods for its use in the extended control of a flea infestation on a domestic animal such as a dog without emesis.
    Type: Application
    Filed: August 4, 2020
    Publication date: November 19, 2020
    Inventors: Douglas Hepler, Roland Johnson, Gail Dempsey, Michael Kelly
  • Publication number: 20200352971
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Application
    Filed: July 23, 2020
    Publication date: November 12, 2020
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas Hepler, Raymond Petzold
  • Patent number: 10736318
    Abstract: A single-dose oral formulation of spinosad and lufenuron and methods for its use in the extended control of a flea infestation on a domestic animal such as a dog without emesis.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: August 11, 2020
    Assignee: Piedmont Animal Health Inc.
    Inventors: Douglas Hepler, Roland Johnson, Gail Dempsey, Michael Kelly
  • Patent number: 10729709
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: August 4, 2020
    Assignee: Piedmont Animal Health Inc.
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas Hepler, Raymond Petzold
  • Publication number: 20190216836
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Application
    Filed: March 20, 2019
    Publication date: July 18, 2019
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas Hepler, Raymond Petzold
  • Patent number: 10286003
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: May 14, 2019
    Assignee: Piedmont Animal Health, LLC
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas Hepler, Raymond Petzold
  • Publication number: 20180279613
    Abstract: A single-dose oral formulation of spinosad and lufenuron and methods for its use in the extended control of a flea infestation on a domestic animal such as a dog without emesis.
    Type: Application
    Filed: March 28, 2018
    Publication date: October 4, 2018
    Inventors: Douglas Hepler, Roland Johnson, Gail Dempsey, Michael Kelly
  • Publication number: 20160361336
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Application
    Filed: June 10, 2016
    Publication date: December 15, 2016
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas Hepler
  • Publication number: 20050140061
    Abstract: A nozzle for an injection molding machine is disclosed. The nozzle includes a nozzle body, an inner nozzle, and an outer nozzle. The nozzle defines two independent flow paths therethrough. The nozzle can simultaneously discharge two materials. A method of using the nozzle and a resulting golf ball product are also disclosed.
    Type: Application
    Filed: December 31, 2003
    Publication date: June 30, 2005
    Inventors: Paul Puniello, Christopher Cavallaro, Christopher Grace, David Crandall, Douglas Hepler
  • Patent number: D883606
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: May 12, 2020
    Assignee: POLYSHOT CORPORATION
    Inventor: Douglas Hepler
  • Patent number: D910969
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: February 23, 2021
    Assignee: POLYSHOT CORPORATION
    Inventor: Douglas Hepler
  • Patent number: D948840
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: April 19, 2022
    Assignee: POLYSHOT CORPORATION
    Inventor: Douglas Hepler